Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of PBF-680 in Healthy Volunteers
NCT02208973Phase 1Completed
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- May 2014
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of PBF-680 in asthma (6 arms), sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Primary endpoint: Number of Participants with Serious and Non-Serious Adverse Events. Started May 2014; status: completed.
02
Drugs
PBF-680
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02208973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02208973.